treatment

Study on the “ABCs of Mental Health” finds that simply believing you can improve mental wellbeing helps actually improve it

by

The num­ber of peo­ple strug­gling with poor men­tal health and men­tal dis­or­ders has been ris­ing around the world over the past few decades. Those who are strug­gling are increas­ing­ly fac­ing dif­fi­cul­ties access­ing the kind of sup­port they need – leav­ing many wait­ing months for help, if they even qual­i­fy for treatment.

While it’s clear that more needs to be done to improve access to treat­ment, it doesn’t mean peo­ple inevitably have to strug­gle with their men­tal health as a result. In fact, there are many things peo­ple can do on their own to main­tain good men­tal health – and even pre­vent men­tal health prob­lems from devel­op­ing in the first place. Accord­ing to our recent research, one of the steps you can take to improve your men­tal well­be­ing may be as sim­ple as believ­ing that you can.

In our recent study, we asked 3,015 Dan­ish adults to fill out a sur­vey that asked ques­tions about men­tal health – such as whether they believe they can do some­thing to keep men­tal­ly healthy, whether they had done some­thing in the past two weeks to sup­port their men­tal health, and also whether they were cur­rent­ly strug­gling with a men­tal health prob­lem. We then assessed their lev­el of men­tal well­be­ing using the Short Warwick–Edinburgh Men­tal Well-being Scale, which is wide­ly used by health­care pro­fes­sion­als and researchers to mea­sure men­tal well­be­ing. [Read more…] about Study on the “ABCs of Men­tal Health” finds that sim­ply believ­ing you can improve men­tal well­be­ing helps actu­al­ly improve it

Digital therapeutics pioneer Akili Interactive plans to go public in mid-2022 at a $1B valuation

by

Pal­i­hapi­tiya-Led SPAC to Merge With Akili in $1 Bil­lion Deal (Bloomberg):

Akili Inter­ac­tive, a start­up that has devel­oped a video game to help treat atten­tion-deficit dis­or­ders in kids, has agreed to go pub­lic through a merg­er with one of Chamath Palihapitiya’s blank-check companies.

The deal, which con­firms a Bloomberg News report, val­ues the com­bined enti­ty at about $1 bil­lion, Akili and Social Cap­i­tal Suvret­ta Hold­ings Corp. I said in a state­ment seen by Bloomberg. It will pro­vide as much as $412 mil­lion in gross cash pro­ceeds, the com­pa­nies said. [Read more…] about Dig­i­tal ther­a­peu­tics pio­neer Akili Inter­ac­tive plans to go pub­lic in mid-2022 at a $1B valuation

Webinar on Tuesday, June 16th: Harnessing neuroplasticity to transform brain rehabilitation

by

Quick heads-up on an oppor­tu­ni­ty for clin­i­cians to learn about an inno­v­a­tive pro­gram trans­form­ing brain injury rehab up in Canada.

When: Tue, June 16, 2020. 3:00 PM – 4:00 PM EDT [Read more…] about Webi­nar on Tues­day, June 16th: Har­ness­ing neu­ro­plas­tic­i­ty to trans­form brain rehabilitation

Large study finds positive yet mixed results from Akili’s digital therapeutic for kids with ADHD

by

__

Full pub­li­ca­tion of piv­otal tri­al data out­lines Akil­i’s case for FDA reg­u­la­tion (Mobi­Health­News):

“A full tran­script of STARS-ADHD — the piv­otal tri­al of Akili Interactive’s video game-like pedi­atric atten­tion deficit treat­ment — has been pub­lished in The Lancet Dig­i­tal Health jour­nal, pro­vid­ing onlook­ers a clear view of data fuel­ing the dig­i­tal ther­a­peu­tic company’s pend­ing FDA sub­mis­sion [Read more…] about Large study finds pos­i­tive yet mixed results from Akili’s dig­i­tal ther­a­peu­tic for kids with ADHD

Machine-learning study finds EEG brain signatures that predict response to antidepressant treatments

by

–

Brain-wave pat­tern can iden­ti­fy peo­ple like­ly to respond to anti­de­pres­sant, study finds (Stan­ford Med­i­cine press release):

“A new method of inter­pret­ing brain activ­i­ty could poten­tial­ly be used in clin­ics to help deter­mine the best treat­ment options for depres­sion, accord­ing to a study led by researchers at the Stan­ford School of Medicine.

Stan­ford researchers and their col­lab­o­ra­tors used elec­troen­cephalog­ra­phy, a tool for mon­i­tor­ing elec­tri­cal activ­i­ty in the brain, and an algo­rithm to iden­ti­fy a brain-wave sig­na­ture in [Read more…] about Machine-learn­ing study finds EEG brain sig­na­tures that pre­dict response to anti­de­pres­sant treatments

Study finds combined pharma + non-pharma treatment most beneficial to help youth with ADHD address long-term academic difficulties

by

__

Aca­d­e­m­ic dif­fi­cul­ties are one of the most impor­tant adverse con­se­quences of ADHD, and they fre­quent­ly con­tribute to par­ents’ deci­sion to seek treat­ment for their child. Whether treat­ment con­sis­tent­ly yields a pos­i­tive impact on long-term aca­d­e­m­ic suc­cess is thus an impor­tant issue; how­ev­er, the answer to this ques­tion has been some­what con­tro­ver­sial. [Read more…] about Study finds com­bined phar­ma + non-phar­ma treat­ment most ben­e­fi­cial to help youth with ADHD address long-term aca­d­e­m­ic difficulties